Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

The Centers for Medicare and Medicaid Services (CMS) ... Medicare won’t cover anti-obesity GLP-1 drugs as Biden admin proposed by Joseph Choi - 04/04/25 6:29 PM ET.

President Trump’s administration has made the decision not to cover highly-popular obesity treatments under the 2026 Medicare Advantage and Part D policies. One day after the Senate confirmed Dr ...

Insulin changed the way we treat and manage diabetes. Chemotherapy has precipitously reduced the mortality rate of certain ...

A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its ...

The Biden administration proposal on obesity drugs. In November 2024, The Biden administration proposed a rule that would allow both Medicare and Medicaid to cover weight loss drugs beginning in ...